Hepatitis B virus infection does not affect the clinical outcome of anti-programmed death receptor-1 therapy in advanced solid malignancies: Real-world evidence from a retrospective study using propensity score matching

This study aimed to investigate the impact of hepatitis B virus (HBV) infection on the outcome of patients with advanced solid malignancies treated with programmed death receptor-1 (PD-1) inhibitors. We retrospectively included patients treated with PD-1 inhibitors between August 2018 and April 2020...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Liting, Zhong, PinShun, Liu, Huafeng, Li, Zelei, Nie, Qihong, Peng, Weiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663830/
https://www.ncbi.nlm.nih.gov/pubmed/34889269
http://dx.doi.org/10.1097/MD.0000000000028113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663830/
https://www.ncbi.nlm.nih.gov/pubmed/34889269
http://dx.doi.org/10.1097/MD.0000000000028113

Ejemplares similares